You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

Article metrics

Article menu

Download PDFPDF

Research Article
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2026

AbstractFullPdf
Dec 2019220
Jan 202012122
Feb 202018518512
Mar 202092927
Apr 202033334
May 2020707015
Jun 202035355
Jul 2020363611
Aug 202030308
Sep 2020444414
Oct 2020424215
Nov 2020404015
Dec 2020464618
Jan 2021535324
Feb 2021606018
Mar 202110110131
Apr 2021565629
May 2021585850
Jun 2021464618
Jul 2021383830
Aug 2021494946
Sep 2021434332
Oct 2021535341
Nov 2021454555
Dec 2021424231
Jan 2022626530
Feb 2022434931
Mar 2022384223
Apr 2022525832
May 2022474932
Jun 2022576420
Jul 2022404517
Aug 202211011120
Sep 2022525464
Oct 2022444421
Nov 2022676940
Dec 202233349
Jan 2023555723
Feb 2023889337
Mar 2023596136
Apr 2023606037
May 2023515226
Jun 2023414121
Jul 2023343417
Aug 202320520516
Sep 2023282812
Oct 2023464719
Nov 2023444414
Dec 2023626217
Jan 2024434522
Feb 2024414111
Mar 2024444429
Apr 2024475029
May 2024323218
Jun 2024424117
Jul 2024697128
Aug 2024222114
Sep 2024333317
Oct 2024505025
Nov 2024424318
Dec 2024676727
Jan 2025424320
Feb 2025485116
Mar 2025394122
Apr 2025484815
May 2025434240
Jun 2025313215
Jul 2025220
Mar 2026110
Total351535771528